Actualités Oct 11, 2023 Orio Therapeutics s’associe à la plus grande université d’Australie pour transformer la médecine régénérative Dans le but de redéfinir la médecine régénérative, l'Université Monash collabore avec la société valaisanne Orio Therapeutics pour innover dans l...
News Dec 02, 2020 Biopharmaceutical giant Lonza to build two new production lines and create 200 new jobs in Valais Following a long-term strategic agreement in the field of bioconjugates with a global biopharmaceutical company, Lonza will build two new product...
Investir en Suisse Industries clés Les entreprises de différentes branches n'ont pas les mêmes besoins concernant la promotion des exportations et ont chacune leurs propres exigenc...
News Jul 13, 2021 Merck reaches key milestone in the construction of its Biotech Development Center Merck has celebrated the completion of the structural work on its Biotech Development Center currently under construction in Corsier-sur-Vevey.
Handbook for Investors Jun 08, 2023 Handbook for Investors The handbook provides information on the most important aspects of Switzerland as a modern and innovative business and technology location. It co...
Tecnologie e settori svizzeri Settori chiave Le associazioni e le organizzazioni di settore, nel loro ruolo di partner della rete nazionale di Switzerland Global Enterprise (S-GE), assicuran...
Report Jul 21, 2021 Key Swiss Circular Economy Features In our current linear economic model the principle of "take-make-waste" dominates. This economic model leads to resource scarcity, waste and ulti...
News Jun 21, 2021 Pharmaplan opens a branch in Visp In response to the investment surge in the pharmaceutical industry, the TTP Group is opening a new Pharmaplan office on the Visp biotechnology si...
News May 10, 2021 Lonza invests CHF 650 million in a new large-scale production facility in Visp Biopharmaceutical giant Lonza has announced expansion plans for next-generation mammalian manufacturing facilities on its Visp site. With an inve...
Technologien + Branchen Branchen Branchenverbände und Sektororganisationen stellen als Partner im nationalen Netzwerk von Switzerland Global Enterprise (S-GE) sicher, dass die In...
News Apr 27, 2021 Lonza invests CHF 200 million in a new production facility in Visp Biopharmaceutical company Lonza will build a new manufacturing facility dedicated to small molecules at its site in Visp. The new investment amou...
Success stories Apr 15, 2020 Switzerland is an interesting playground for IBM to develop artificial intelligence IBM Switzerland This year's Swiss Biotech Report by the Swiss Biotech Association outlines a new decade - a decade in which Switzerland can rely on a compre...
News Jan 09, 2024 Molecular Partners and Orano Med announce strategic partnership Molecular Partners and Orano Med are joining forces for the development of protein drugs known as DARPin therapeutics. The radioactive payloads o...
Actualités Oct 31, 2023 Debiopharm augmente ses effectifs et investit CHF 30 millions en Valais Debiopharm Research & Manufacturing a annoncé un investissement de plus de CHF 30 millions dans l’agrandissement de son laboratoire de Martigny, ...
News Jul 26, 2023 LimmaTech Bio cooperating with GSK on vaccine development The biotechnology firm LimmaTech Biologics has concluded a license agreement with GlaxoSmithKline Biologicals (GSK). In this way, LimmaTech is se...
News Jan 04, 2021 Zifo RnD Solutions coming to Basel Zifo RnD Solutions, a global provider of IT solutions for research-based organizations, opens its latest subsidiary in Basel. With Zifo Switzerla...
Fact Sheet May 04, 2022 Advanced Manufacturing in Switzerland As a production location, Switzerland offers companies optimal conditions to optimize their manufacturing processes through increased efficiency ...